GXFC3 (Combivir 150 mg / 300 mg)
Generic Name: lamivudine/zidovudine
Pill imprint GXFC3 has been identified as Combivir 150 mg / 300 mg.
Combivir is used in the treatment of occupational exposure; nonoccupational exposure; hiv infection and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Combivir 150 mg / 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- lamivudine/zidovudine
- Imprint:
- GXFC3
- Strength:
- 150 mg / 300 mg
- Color:
- White
- Size:
- 17.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antiviral combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00173-0595
- Inactive Ingredients:
- silicon dioxide colloidal
hypromelloses
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide
More about Combivir (lamivudine / zidovudine)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
